Read + Share
Amedeo Smart
Independent Medical Education
Ahmed W, Scott FI. Closing the gap: the real-world risk of serious infections with vedolizumab in comparison to anti-TNF therapy in inflammatory bowel disease. Clin Gastroenterol Hepatol 2021 May 19. pii: S1542-3565(21)00564.PMID: 34022455
Email
LinkedIn
Facebook
Twitter
Privacy Policy